Although more detailed statistical analyses in the larger cohort are required, current study suggested that, as a genetic predictive marker, TAS2R38 bitterness receptor variations may have a large implication in obesity prevention and treatment. The gene discussed is TAS2R38; the disease is obesity due to melanocortin 4 receptor deficiency.